Novartis AG (NOVN.SW)
| Previous Close | 99.27 |
| Open | 99.49 |
| Bid | 98.71 x 0 |
| Ask | 98.73 x 0 |
| Day's Range | 98.69 - 100.08 |
| 52 Week Range | 83.00 - 102.72 |
| Volume | |
| Avg. Volume | 2,856,755 |
| Market Cap | 199.846B |
| Beta (5Y Monthly) | 0.50 |
| PE Ratio (TTM) | 23.61 |
| EPS (TTM) | 4.18 |
| Earnings Date | Oct 29, 2024 |
| Forward Dividend & Yield | 3.30 (3.32%) |
| Ex-Dividend Date | Mar 07, 2024 |
| 1y Target Est | 86.92 |
ZacksHere's Why Novartis (NVS) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ReutersSwiss competition authority closes Novartis probe without consequences
BERLIN (Reuters) -Switzerland's COMCO competition commission terminated an investigation against Novartis into possibly using blocking patents, without consequences, it said on Thursday. COMCO opened the probe in September 2022 to determine whether the pharmaceutical giant intended to unlawfully protect one if its medicines by filing various patent infringement lawsuits, the commission said in a statement. "The investigation revealed that Novartis' actions finally were common practice in the field of patent law and, further, did not confirm the above indications of an unlawful restraint of competition," it said in the statement.
ZacksNVS or LLY: Which Is the Better Value Stock Right Now?
NVS vs. LLY: Which Stock Is the Better Value Option?
